Cargando…
Pharmacokinetics of cannabidiol following single oral and oral transmucosal administration in dogs
INTRODUCTION: In the last few years, different formulations containing cannabidiol (CBD) were tested with regard to its efficacy on chronic pain, refractory epilepsy, anxiety, aggressive behavior and atopic dermatitis in dogs. CBD is generally administered orally, but its low bioavailability, probab...
Autores principales: | della Rocca, Giorgia, Paoletti, Fabiola, Conti, Maria Beatrice, Galarini, Roberta, Chiaradia, Elisabetta, Sforna, Monica, Dall'Aglio, Cecilia, Polisca, Angela, Di Salvo, Alessandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859632/ https://www.ncbi.nlm.nih.gov/pubmed/36686155 http://dx.doi.org/10.3389/fvets.2022.1104152 |
Ejemplares similares
-
Pharmacokinetics, efficacy, and safety of cannabidiol in dogs: an update of current knowledge
por: Di Salvo, Alessandra, et al.
Publicado: (2023) -
Plasma Pharmacokinetics of Cannabidiol Following Oral Administration of Cannabidiol Oil to Dairy Calves
por: Meyer, Kelsey, et al.
Publicado: (2022) -
Pharmacokinetics of Cannabidiol Following Intranasal, Intrarectal, and Oral Administration in Healthy Dogs
por: Polidoro, Dakir, et al.
Publicado: (2022) -
Pharmacokinetic modelling of orally administered cannabidiol and implications for medication control in horses
por: Eichler, Fabienne, et al.
Publicado: (2023) -
Tumor-Associated Macrophages in Canine Oral and Cutaneous Melanomas and Melanocytomas: Phenotypic and Prognostic Assessment
por: Porcellato, Ilaria, et al.
Publicado: (2022)